NCT06222762

Brief Summary

France has one million people with heart failure (HF). Exercise intolerance, characterised by dyspnoea, is the main clinical symptom in HF patients and a key determinant of reduced quality of life. In addition to drug and surgical treatments, cardiac rehabilitation programmes have shown benefits in heart failure patients. Lasting at least 3 weeks, these programmes improve physical abilities, quality of life and reduce the risk of hospitalisation for heart failure patients. To date, the real challenge is no longer to prove the benefits of cardiac rehabilitation, but to find solutions to maintain its long-term effects. The transition between the end of the supervised programmes in the centre and the return home is a difficult phase for the majority of patients who do not continue regular physical activity and thus quickly lose the benefits of the programme. To help maintain the benefits of cardiac rehabilitation, some centres offer patients programmes to continue physical activity during phase III. Although these options are often beneficial in the first few months after the end of rehabilitation compared to control groups, the long-term results are mixed. These results imply that one of these maintenance options may not be suitable for all patients. It is therefore important to propose a personalised post-rehabilitation follow-up involving the patient in the choice of physical activities to optimise the maintenance of long-term benefits. We hypothesise that patients who receive personalised support from a sport and health professional following rehabilitation maintain long-term benefits compared to a control group who do not receive this support.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
17mo left

Started Feb 2024

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Feb 2024Sep 2027

First Submitted

Initial submission to the registry

October 26, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 25, 2024

Completed
19 days until next milestone

Study Start

First participant enrolled

February 13, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2027

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

3.6 years

First QC Date

October 26, 2023

Last Update Submit

September 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare the evolution of the level of physical activity 12 months after a cardiac rehabilitation programme between patients benefiting from personalised support at the end of the rehabilitation and a control group benefiting from the usual management.

    The primary endpoint will be the difference in mean daily steps measured by accelerometry (over 7 days) at the start of the rehabilitation course (Visit 1) and after 12 months of personalised follow-up (Visit 4).

    12 months

Secondary Outcomes (20)

  • To compare between the experimental group and the control group, the evolution 12 months after a cardiac rehabilitation programme of time spent in each level of activity :

    12 months

  • To compare physical capacities measured using the 6-minute walk test between the experimental group and the control group, the evolution 12 months after a cardiac rehabilitation programme

    12 months

  • To compare physical capacities measured using the endurance test between the experimental group and the control group, the evolution 12 months after a cardiac rehabilitation programme

    12 months

  • To compare physical capacities measured using the chair getting-up test between the experimental group and the control group, the evolution 12 months after a cardiac rehabilitation programme

    12 months

  • To compare physical capacities measured using the hand-grip test between the experimental group and the control group, the evolution 12 months after a cardiac rehabilitation programme

    12 months

  • +15 more secondary outcomes

Study Arms (2)

Commun practice

NO INTERVENTION

Patient in the control arm will not beneficiate from a follow-up in adapted physical activities (commun practice)

Follow-up in adapted physical activities

EXPERIMENTAL

Patient in the control arm will beneficiate from a follow-up in adapted physical activities

Other: Experimental arm

Interventions

Personalized follow-up in adapted physical activities

Follow-up in adapted physical activities

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stable heart failure with NYHA stage I, II or III
  • Participation in a cardiac rehabilitation programme
  • Patient agreement
  • Patient of legal age
  • Patient affiliated to the Social Security

You may not qualify if:

  • Patient refusal
  • Minor patients
  • Subjects under guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fondation ILDYS

Brest, 29200, France

RECRUITING

CHU de Brest

Brest, 29609, France

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Jacques Mansourati, MD, PhD

    Brest Universty Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacques Mansourati, MD, PhD

CONTACT

Baptiste Chéhère, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomised controlled trial of superiority in parallel arms. Randomised parallel group trial divided into groups according to a ratio (1:1) comparing the follow-up and personalised support after a cardiac rehabilitation programme (experimental group) versus a control group receiving only the usual care, i.e. without follow-up by a sports-health professional (control group), in patients with heart failure.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2023

First Posted

January 25, 2024

Study Start

February 13, 2024

Primary Completion (Estimated)

September 13, 2027

Study Completion (Estimated)

September 13, 2027

Last Updated

September 11, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning five years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations